Compare · EW vs WLFC
EW vs WLFC
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Willis Lease Finance Corporation (WLFC): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while WLFC operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $50.78B, about 62.5x WLFC ($813.0M).
- EW has been more active in the news (5 items in the past 4 weeks vs 2 for WLFC).
- EW has more recent analyst coverage (25 ratings vs 1 for WLFC).
- Company
- Edwards Lifesciences Corporation
- Willis Lease Finance Corporation
- Price
- $86.61-1.66%
- $37.58-2.24%
- Market cap
- $50.78B
- $813.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 1996
- News (4w)
- 5
- 2
- Recent ratings
- 25
- 1
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Willis Lease Finance Corporation
Willis Lease Finance Corporation operates as a lessor and servicer of commercial aircraft and aircraft engines worldwide. The company operates through two segments, Leasing and Related Operations, and Spare Parts Sales. The Leasing and Related Operations segment engages in acquiring and leasing commercial aircraft, aircraft engines, and other aircraft equipment, as well as the purchase and resale of commercial aircraft engines and other aircraft equipment, and other related businesses. The Spare Parts Sales segment purchases and resells after-market engine parts, whole engines, engine modules, and portable aircraft components. Willis Lease Finance Corporation was founded in 1985 and is headquartered in Coconut Creek, Florida.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest WLFC
- SVP, GC & Corporate Secretary Dameron Clifton covered exercise/tax liability with 1,420 shares, decreasing direct ownership by 4% to 38,038 units (SEC Form 4) (for tax liability)
- Willis Lease Finance Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Willis Lease Finance Corporation filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Announcement of Series B Preferred Stock Purchase Agreement
- EVP, CFO Flaherty Scott B. sold $1,633,487 worth of shares (30,000 units at $54.45), decreasing direct ownership by 12% to 214,324 units (SEC Form 4)
- Deutsche Bank initiated coverage on Willis Lease with a new price target
- Willis Lease Finance Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 4 filed by Willis Lease Finance Corporation
- Executive Chairman Willis Charles F Iv sold $21,180 worth of shares (400 units at $52.95) (SEC Form 4)
- Executive Chairman Willis Charles F Iv sold $1,481,220 worth of shares (27,000 units at $54.86) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 2,492,143 units (SEC Form 4)